Quantification of five neuropsychological approaches to defining mild cognitive impairment

Amy J Jak1, Mark W Bondi, Lisa Delano-Wood

  • 1VA San Diego Healthcare System, San Diego, CA 92161, USA. ajak@ucsd.edu

Abstract

Insights

Diagnostic criteria for mild cognitive impairment (MCI) subtypes vary, impacting diagnosis. This study shows that using comprehensive neuropsychological assessments is crucial for stable MCI diagnosis, especially for nonamnestic subtypes.

Area of Science:

  • Gerontology
  • Neuropsychology
  • Cognitive Science

Background:

  • Operational definitions for mild cognitive impairment (MCI) lack standardization.
  • Variability in diagnostic criteria significantly affects MCI subtype classification.
  • Standardizing MCI diagnosis is essential for accurate research and clinical practice.

Purpose of the Study:

  • To investigate the applicability of MCI diagnostic criteria in a community-dwelling elder sample.
  • To quantify diagnostic outcome variability due to modified neuropsychological assessments.
  • To examine the stability of MCI subtypes over time.

Main Methods:

  • Cross-sectional and longitudinal study design.
  • Involved 90 community-dwelling older adults, with 73 followed up after 17 months.
  • Utilized five diagnostic strategies varying in objective impairment cutoffs and test inclusion for MCI classification.

Main Results:

  • Diagnosis of MCI versus cognitively normal varied widely (10-74%) based on classification criteria.
  • A significant minority of individuals showed diagnostic instability over time and across methods.
  • The nonamnestic MCI subtype was particularly unstable, often reclassified as normal at follow-up.

Conclusions:

  • Empirical support for neuropsychologically derived MCI subtype definitions.
  • Comprehensive neuropsychological assessments are vital for accurate MCI diagnosis.
  • The utility of nonamnestic MCI subtype diagnosis requires further investigation due to its instability.

Related Concept Videos

Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Intellectual Disability01:29

Intellectual Disability

Intellectual disability (ID) is a neurodevelopmental condition characterized by deficits in intellectual and adaptive functioning that manifest during the developmental period. This condition encompasses challenges in reasoning, memory, problem-solving, and learning, accompanied by impairments in everyday life skills, such as communication, self-care, and social interactions. Intellectual disability affects approximately 1% of the population in the United States, impacting an estimated 5...
Dementia01:30

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual.
Diagnostic and Statistical Manual of Mental Disorders (DSM)01:27

Diagnostic and Statistical Manual of Mental Disorders (DSM)

The Diagnostic and Statistical Manual of Mental Disorders (DSM) serves as the primary classification system for mental health disorders, providing standardized diagnostic criteria for clinicians and researchers. First published by the American Psychiatric Association (APA) in 1952, the DSM has undergone several revisions to reflect evolving psychiatric understanding. The fifth edition, DSM-5, released in 2013, introduced key updates that expanded diagnostic categories and modified diagnostic...
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists01:30

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function. They...